Impact of Intraoperative Cell Salvage on Circulating Tumor Cells and Cellular Activity in Patients with Hepatocellular Carcinoma Undergoing Curative Resection: A Prospective Comparative Study
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ahn JC, Teng PC, Chen PJ et al. (2021) Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma. Hepatology 73:422–436. https://doi.org/10.1002/hep.31165AhnJCTengPCChenPJ2021Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinomaHepatology73422436https://doi.org/10.1002/hep.31165Search in Google Scholar
Aijtink VJ, Rutten VC, Meijer BEM et al. (2022) Safety of intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: A Systematic review and meta-analysis. Ann Surg 276:239–245. https://doi.org/10.1097/SLA.0000000000005476AijtinkVJRuttenVCMeijerBEM2022Safety of intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: A Systematic review and meta-analysisAnn Surg276239245https://doi.org/10.1097/SLA.0000000000005476Search in Google Scholar
Carroll C, Young F (2021) Intraoperative cell salvage. BJA Educ 21:95–101. https://doi.org/10.1016/j.bjae.2020.11.007CarrollCYoungF2021Intraoperative cell salvageBJA Educ2195101https://doi.org/10.1016/j.bjae.2020.11.007Search in Google Scholar
Espejo-Cruz ML, González-Rubio S, Zamora-Olaya J et al. (2021) Circulating tumor cells in hepatocellular carcinoma: A comprehensive review and critical appraisal. Int J Mol Sci 22:13073. https://doi.org/10.3390/ijms222313073Espejo-CruzMLGonzález-RubioSZamora-OlayaJ2021Circulating tumor cells in hepatocellular carcinoma: A comprehensive review and critical appraisalInt J Mol Sci2213073https://doi.org/10.3390/ijms222313073Search in Google Scholar
Ganesan P, Kulik LM (2023) Hepatocellular carcinoma: New developments. Clin Liver Dis 27:85–102. https://doi.org/10.1016/j.cld.2022.08.004GanesanPKulikLM2023Hepatocellular carcinoma: New developmentsClin Liver Dis2785102https://doi.org/10.1016/j.cld.2022.08.004Search in Google Scholar
Ivanics T, Shubert CR, Muaddi H et al. (2021) Blood cell salvage and autotransfusion does not worsen oncologic outcomes following liver transplantation with incidental hepatocellular carcinoma: A propensity score-matched analysis. Ann Surg Oncol 28:6816–6825. https://doi.org/10.1245/s10434-021-09863-6IvanicsTShubertCRMuaddiH2021Blood cell salvage and autotransfusion does not worsen oncologic outcomes following liver transplantation with incidental hepatocellular carcinoma: A propensity score-matched analysisAnn Surg Oncol2868166825https://doi.org/10.1245/s10434-021-09863-6Search in Google Scholar
Jiang Y, Han Q, Zhao H et al. (2021) Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis. J Exp Clin Cancer Res 40:13. https://doi.org/10.1186/s13046-020-01808JiangYHanQZhaoH2021Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysisJ Exp Clin Cancer Res4013https://doi.org/10.1186/s13046-020-01808Search in Google Scholar
Koch DT, Yu H, Beirith I et al. (2023) Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells. J Transl Med 21:876. https://doi.org/10.1186/s12967-023-04615-4KochDTYuHBeirithI2023Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cellsJ Transl Med21876https://doi.org/10.1186/s12967-023-04615-4Search in Google Scholar
Lin D, Shen L, Luo M et al. (2021) Circulating tumor cells: Biology and clinical significance. Signal Transduct Target Ther 6:404. https://doi.org/10.1038/s41392-021-00817-8LinDShenLLuoM2021Circulating tumor cells: Biology and clinical significanceSignal Transduct Target Ther6404https://doi.org/10.1038/s41392-021-00817-8Search in Google Scholar
Liu Y, Tao S, Liao L et al. (2020) TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway. Nat Commun 11:348. https://doi.org/10.1038/s41467-019-14190-2LiuYTaoSLiaoL2020TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathwayNat Commun11348https://doi.org/10.1038/s41467-019-14190-2Search in Google Scholar
Obore N, Liuxiao Z, Haomin Y et al. (2022) Intraoperative cell salvage for women at high risk of postpartum hemorrhage during cesarean section: A systematic review and meta-analysis. Reprod Sci 29:3161–3176. https://doi.org/10.1007/s43032-021-00824-8OboreNLiuxiaoZHaominY2022Intraoperative cell salvage for women at high risk of postpartum hemorrhage during cesarean section: A systematic review and meta-analysisReprod Sci2931613176https://doi.org/10.1007/s43032-021-00824-8Search in Google Scholar
Peng C, Li X, Ao F et al. (2023) Mitochondrial ROS driven by NOX4 upregulation promotes hepatocellular carcinoma cell survival after incomplete radiofrequency ablation by inducing of mitophagy via Nrf2/PINK1. J Transl Med 21:218. https://doi.org/10.1186/s12967-023-04067-wPengCLiXAoF2023Mitochondrial ROS driven by NOX4 upregulation promotes hepatocellular carcinoma cell survival after incomplete radiofrequency ablation by inducing of mitophagy via Nrf2/PINK1J Transl Med21218https://doi.org/10.1186/s12967-023-04067-wSearch in Google Scholar
Pinto MA, Grezzana-Filho TJM, Chedid AD et al. (2021) Impact of intraoperative blood salvage and autologous transfusion during liver transplantation for hepatocellular carcinoma. Langenbecks Arch Surg 406:67–74. https://doi.org/10.1007/s00423-020-01997-7PintoMAGrezzana-FilhoTJMChedidAD2021Impact of intraoperative blood salvage and autologous transfusion during liver transplantation for hepatocellular carcinomaLangenbecks Arch Surg4066774https://doi.org/10.1007/s00423-020-01997-7Search in Google Scholar
Rajasekaran RB, Palmer AJR, Whitwell D et al. (2021) The role of intraoperative cell salvage for musculoskeletal sarcoma surgery. J Bone Oncol 30:100390. https://doi.org/10.1016/j.jbo.2021.100390RajasekaranRBPalmerAJRWhitwellD2021The role of intraoperative cell salvage for musculoskeletal sarcoma surgeryJ Bone Oncol30100390https://doi.org/10.1016/j.jbo.2021.100390Search in Google Scholar
Sun B, Ji WD, Wang WC et al. (2023) Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma. Front Genet 14:1265866. https://doi.org/10.3389/fgene.2023.1265866SunBJiWDWangWC2023Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinomaFront Genet141265866https://doi.org/10.3389/fgene.2023.1265866Search in Google Scholar
Vogel A, Meyer T, Sapisochin G et al. (2022) Hepatocellular carcinoma. Lancet 400:1345–1362. https://doi.org/10.1016/S0140-6736)22)01200-4VogelAMeyerTSapisochinG2022Hepatocellular carcinomaLancet40013451362https://doi.org/10.1016/S0140-6736)22)01200-4Search in Google Scholar
Walton TJ, Huntley D, Whitehouse SL et al. (2023) Intraoperative cell salvage in revision hip arthroplasty. Bone Joint J 105-b:1038–1044. https://doi.org/10.1302/0301-620X.105B10.BJJ-2023-0300.R1WaltonTJHuntleyDWhitehouseSL2023Intraoperative cell salvage in revision hip arthroplastyBone Joint J105-b10381044https://doi.org/10.1302/0301-620X.105B10.BJJ-2023-0300.R1Search in Google Scholar
Wang Y, Deng B (2023) Hepatocellular carcinoma: Molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev 42:629–652. https://doi.org/10.1007/s10555-023-10084-4WangYDengB2023Hepatocellular carcinoma: Molecular mechanism, targeted therapy, and biomarkersCancer Metastasis Rev42629652https://doi.org/10.1007/s10555-023-10084-4Search in Google Scholar
Weller A, Seyfried T, Ahrens N et al. (2021) Cell salvage during liver transplantation for hepatocellular carcinoma: A retrospective analysis of tumor recurrence following irradiation of the salvaged blood. Transplant Proc 53:1639–1644. https://doi.org/10.1016/j.transproceed.2021.03.025WellerASeyfriedTAhrensN2021Cell salvage during liver transplantation for hepatocellular carcinoma: A retrospective analysis of tumor recurrence following irradiation of the salvaged bloodTransplant Proc5316391644https://doi.org/10.1016/j.transproceed.2021.03.025Search in Google Scholar
Yang X, Yang C, Zhang S et al. (2024) Precision treatment in advanced hepatocellular carcinoma. Cancer Cell 42:180–197. https://doi.org/10.1016/j.ccell.2024.01.007YangXYangCZhangS2024Precision treatment in advanced hepatocellular carcinomaCancer Cell42180197https://doi.org/10.1016/j.ccell.2024.01.007Search in Google Scholar